2016 Q1 Form 10-Q Financial Statement
#000156459016018000 Filed on May 05, 2016
Income Statement
| Concept | 2016 Q1 | 2015 Q1 |
|---|---|---|
| Revenue | $3.942M | $13.49M |
| YoY Change | -70.78% | 66.23% |
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $5.360M | $4.730M |
| YoY Change | 13.32% | 29.95% |
| % of Gross Profit | ||
| Research & Development | $15.27M | $14.98M |
| YoY Change | 1.91% | 23.98% |
| % of Gross Profit | ||
| Depreciation & Amortization | $245.0K | $147.0K |
| YoY Change | 66.67% | 19.51% |
| % of Gross Profit | ||
| Operating Expenses | $20.62M | $19.71M |
| YoY Change | 4.62% | 25.34% |
| Operating Profit | -$16.68M | -$6.221M |
| YoY Change | 168.14% | -18.26% |
| Interest Expense | $190.0K | $150.0K |
| YoY Change | 26.67% | 275.0% |
| % of Operating Profit | ||
| Other Income/Expense, Net | ||
| YoY Change | ||
| Pretax Income | -$16.49M | -$6.067M |
| YoY Change | 171.86% | -19.88% |
| Income Tax | $0.00 | -$748.0K |
| % Of Pretax Income | ||
| Net Earnings | -$16.49M | -$5.319M |
| YoY Change | 210.1% | -29.75% |
| Net Earnings / Revenue | -418.42% | -39.43% |
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$234.3K | -$76.79K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 69.17M | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2016 Q1 | 2015 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $188.6M | $225.7M |
| YoY Change | -16.45% | 5.78% |
| Cash & Equivalents | $33.01M | $25.26M |
| Short-Term Investments | $155.6M | $200.5M |
| Other Short-Term Assets | $600.0K | $1.000M |
| YoY Change | -40.0% | 186.53% |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | $2.600M | $6.600M |
| Other Receivables | $400.0K | $400.0K |
| Total Short-Term Assets | $191.1M | $203.9M |
| YoY Change | -6.28% | -7.41% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $3.200M | $3.000M |
| YoY Change | 6.67% | 112.77% |
| Goodwill | $1.585M | |
| YoY Change | 0.0% | |
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $1.000M | $29.80M |
| YoY Change | -96.64% | -1.97% |
| Other Assets | $100.0K | $157.0K |
| YoY Change | -36.31% | |
| Total Long-Term Assets | $5.900M | $34.61M |
| YoY Change | -82.95% | -1.94% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $191.1M | $203.9M |
| Total Long-Term Assets | $5.900M | $34.61M |
| Total Assets | $197.0M | $238.5M |
| YoY Change | -17.4% | -6.65% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $3.100M | $6.800M |
| YoY Change | -54.41% | 11.48% |
| Accrued Expenses | $1.700M | $1.700M |
| YoY Change | 0.0% | 13.33% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $10.10M | $19.97M |
| YoY Change | -49.42% | 21.71% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $200.0K | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $7.300M | $11.00M |
| YoY Change | -33.64% | -47.37% |
| Total Long-Term Liabilities | $7.500M | $11.00M |
| YoY Change | -31.82% | -47.37% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $10.10M | $19.97M |
| Total Long-Term Liabilities | $7.500M | $11.00M |
| Total Liabilities | $17.60M | $31.02M |
| YoY Change | -43.26% | -18.54% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$333.9M | |
| YoY Change | 7.8% | |
| Common Stock | $541.3M | |
| YoY Change | 79742.48% | |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $179.4M | $207.5M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $197.0M | $238.5M |
| YoY Change | -17.4% | -6.65% |
Cashflow Statement
| Concept | 2016 Q1 | 2015 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$16.49M | -$5.319M |
| YoY Change | 210.1% | -29.75% |
| Depreciation, Depletion And Amortization | $245.0K | $147.0K |
| YoY Change | 66.67% | 19.51% |
| Cash From Operating Activities | -$20.40M | -$2.400M |
| YoY Change | 750.0% | -121.09% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $252.0K | $1.084M |
| YoY Change | -76.75% | 760.32% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$16.00M | $19.50M |
| YoY Change | -182.05% | 387.5% |
| Cash From Investing Activities | -$16.30M | $18.40M |
| YoY Change | -188.59% | 373.37% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $187.0K | $3.178M |
| YoY Change | -94.12% | -58.1% |
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 200.0K | 3.200M |
| YoY Change | -93.75% | -96.84% |
| NET CHANGE | ||
| Cash From Operating Activities | -20.40M | -2.400M |
| Cash From Investing Activities | -16.30M | 18.40M |
| Cash From Financing Activities | 200.0K | 3.200M |
| Net Change In Cash | -36.50M | 19.20M |
| YoY Change | -290.1% | -83.54% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$20.40M | -$2.400M |
| Capital Expenditures | $252.0K | $1.084M |
| Free Cash Flow | -$20.65M | -$3.484M |
| YoY Change | 492.77% | -130.96% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2016Q1 | sgmo |
Build To Suit Lease Obligations
BuildToSuitLeaseObligations
|
213000 | |
| CY2015Q4 | us-gaap |
Liabilities
Liabilities
|
24796000 | |
| CY2015Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2015Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
703000 | |
| CY2016Q1 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
231000 | |
| CY2016Q1 | us-gaap |
Revenues
Revenues
|
3942000 | |
| CY2016Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-16681000 | |
| CY2015Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6221000 | |
| CY2015Q1 | us-gaap |
Revenues
Revenues
|
13491000 | |
| CY2015Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
560989000 | |
| CY2015Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-369253000 | |
| CY2016Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
83000 | |
| CY2016Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
15266000 | |
| CY2015Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
14980000 | |
| CY2016Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5357000 | |
| CY2015Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4732000 | |
| CY2016Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
20623000 | |
| CY2015Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
19712000 | |
| CY2016Q1 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
187000 | |
| CY2015Q1 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
154000 | |
| CY2016Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-16494000 | |
| CY2015Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-6067000 | |
| CY2015Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-748000 | |
| CY2015Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
-1800000 | |
| CY2015Q1 | us-gaap |
Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
|
1870000 | |
| CY2015Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-748000 | |
| CY2015Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-25000 | |
| CY2015Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-3730000 | |
| CY2015Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-101000 | |
| CY2015Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-2477000 | |
| CY2015Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-1150000 | |
| CY2015Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
34000 | |
| CY2015Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-2393000 | |
| CY2015Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
39423000 | |
| CY2015Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
58955000 | |
| CY2015Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1084000 | |
| CY2015Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
18448000 | |
| CY2015Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
7000 | |
| CY2016Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
187000 | |
| CY2015Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
3178000 | |
| CY2015Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2916000 | |
| CY2016Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-16494000 | |
| CY2016Q1 | us-gaap |
Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
|
1003000 | |
| CY2016Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.23 | |
| CY2016Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
70373000 | |
| CY2016Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
83000 | |
| CY2016Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-16411000 | |
| CY2016Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
245000 | |
| CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
192439000 | |
| CY2015Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
217235000 | |
| CY2015Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
160000000 | |
| CY2015Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
70354608 | |
| CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
70354608 | |
| CY2015Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
152000 | |
| CY2015Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
2748000 | |
| CY2015Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
9120000 | |
| CY2015Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
20097000 | |
| CY2015Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
4699000 | |
| CY2015Q4 | us-gaap |
Goodwill
Goodwill
|
1585000 | |
| CY2015Q4 | us-gaap |
Assets
Assets
|
217235000 | |
| CY2015Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
8229000 | |
| CY2015Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5319000 | |
| CY2015Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.08 | |
| CY2015Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
69283000 | |
| CY2015Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
50000 | |
| CY2015Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-5269000 | |
| CY2015Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
147000 | |
| CY2016Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-72000 | |
| CY2015Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-241000 | |
| CY2016Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3194000 | |
| CY2015Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2953000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
95000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
46000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-172000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-5158000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-1026000 | |
| CY2016Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1224000 | |
| CY2016Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-20360000 | |
| CY2016Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
84816000 | |
| CY2016Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
68770000 | |
| CY2016Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
252000 | |
| CY2016Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-16298000 | |
| CY2016Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
2000 | |
| CY2015Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
3171000 | |
| CY2016Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
185000 | |
| CY2016Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-36473000 | |
| CY2015Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
19226000 | |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
6030000 | |
| CY2015Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
25256000 | |
| CY2016Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
253000 | |
| CY2015Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
579000 | |
| CY2016Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-bottom:0pt;margin-top:18pt;margin-left:2.26%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. On an ongoing basis, management evaluates its estimates, including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. During the first quarter of 2016, we revised the estimated performance period of the upfront Biogen license through June 2019. This change increased net loss by $0.9 million and increased our basic net loss per share by $0.01 for the three month period ended March 31, 2016.</p></div> | |
| CY2016Q1 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
28057000 | |
| CY2016Q1 | us-gaap |
Marketable Securities
MarketableSecurities
|
155575000 | |
| CY2016Q1 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
183632000 | |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
65937000 | |
| CY2015Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
139518000 | |
| CY2015Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
205455000 | |
| CY2016Q1 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
183533000 | |
| CY2015Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
205440000 | |
| CY2016Q1 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
107000 | |
| CY2016Q1 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
8000 | |
| CY2015Q4 | us-gaap |
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
36000 | |
| CY2016Q1 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
183632000 | |
| CY2015Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
205455000 | |
| CY2016Q1 | sgmo |
Other Than Temporarily Impaired Investment
OtherThanTemporarilyImpairedInvestment
|
0 | |
| CY2015Q4 | sgmo |
Other Than Temporarily Impaired Investment
OtherThanTemporarilyImpairedInvestment
|
0 | |
| CY2016Q1 | sgmo |
Investments Maturity Dates Available For Sale Securities
InvestmentsMaturityDatesAvailableForSaleSecurities
|
P2Y | |
| CY2015 | sgmo |
Investments Maturity Dates Available For Sale Securities
InvestmentsMaturityDatesAvailableForSaleSecurities
|
P2Y | |
| CY2016Q1 | us-gaap |
Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
|
0 | |
| CY2016Q1 | us-gaap |
Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
|
0 | |
| CY2014Q1 | sgmo |
Number Of Research Program
NumberOfResearchProgram
|
2 | |
| CY2016Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3194000 | |
| CY2015Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2953000 | |
| CY2015Q4 | sgmo |
Build To Suit Lease Property Leased
BuildToSuitLeasePropertyLeased
|
41400 | |
| CY2015Q4 | us-gaap |
Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
|
P5Y | |
| CY2015Q4 | sgmo |
Operating Leases Number Of Extension Options
OperatingLeasesNumberOfExtensionOptions
|
2 | |
| CY2016Q1 | sgmo |
Build To Suit Lease Costs Capitalized
BuildToSuitLeaseCostsCapitalized
|
200000 |
